President Donald Trump has directed federal health officials to conduct a new review of the nation’s childhood vaccination schedule, a move that could lead to additional changes in the vaccines routinely recommended for American children and teenagers.

The executive order, signed Friday, builds on a scientific evaluation issued earlier this year by the U.S. Department of Health and Human Services. That report highlighted that the United States recommends a larger number of childhood vaccines than other developed nations and administers significantly more doses than some countries in Europe.

Following the release of that assessment, the Centers for Disease Control and Prevention revised its childhood immunization guidance in January, reducing the number of routinely recommended vaccinations from 17 to 11. The decision drew strong opposition from many medical organizations and public health experts.

Under the updated CDC recommendations, vaccines for respiratory syncytial virus (RSV), hepatitis A, hepatitis B, dengue fever, meningococcal ACWY, and meningococcal B are generally recommended only for children considered to be at elevated risk.

The agency maintained its existing recommendations for protection against 11 illnesses, including measles, mumps, rubella, whooping cough, tetanus, diphtheria, Haemophilus influenzae type b, pneumonia, polio, human papillomavirus (HPV), and chickenpox.

Trump’s executive order instructs the CDC and its Advisory Committee on Immunization Practices (ACIP) to reexamine both the January HHS report and the most recent clinical research. The review is intended to determine whether further revisions should be made to the national vaccine schedule for children and adolescents.

In a fact sheet released alongside the order, the White House said: “President Trump is reaffirming his commitment to gold-standard science, ensuring Americans receive the best possible medical advice, and empowering patients and doctors with maximum flexibility.”

The American Academy of Pediatrics took a different approach after the January CDC changes, issuing its own immunization guidelines that continue to recommend routine protection against 18 diseases. Those recommendations include vaccines for RSV, hepatitis A, hepatitis B, rotavirus, influenza, and meningococcal disease.

AAP officials have argued that comparisons between the United States and other countries can be misleading because vaccine recommendations are based on each nation’s unique public health conditions and healthcare infrastructure.

“We don’t follow Denmark’s vaccine recommendations because we don’t live in Denmark,” Dr. Jose Romero, a member of AAP’s committee on infectious diseases, said in a statement last year. “Children in the United States are at risk of different diseases than children in other countries. We also have a completely different health system.”

The American College of Physicians also voiced concern over the administration’s latest action, warning against replacing longstanding U.S. guidance with policies modeled after those of other countries.

“This is the second time the administration has attempted to unilaterally substitute vaccine guidance from other countries to replace the U.S. vaccine schedule which was developed for the specific needs of the U.S. population,” ACP President Dr. Jan Carney said in a statement. “The U.S. childhood vaccine schedule was designed through years of transparent, scientific review focused on preventing serious illness, outbreaks and deaths among our country’s large, diverse population with uneven access to health care services.

“The evidence is clear: vaccines are safe and effective at preventing deaths, hospitalizations and the spread of disease,” she added. “The changes that this executive order directs cannot be allowed to move forward.”

{Matzav.com}